Corsicana & Co’s Pfizer PFE Stock Holding History

Corsicana & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63K	Buy	2,615 +315	+14%	+$8.24K	0.03%	144
2026 Q1	$58.3K	Sell	2,300 -235	-9%	-$6.26K	0.04%	124
2025 Q4	$63.1K	Hold	2,535	–	–	0.04%	127
2025 Q3	$64.6K	Buy	+2,535	New	+$62.6K	0.04%	127
2022 Q3	$189K	Hold	4,315	–	–	0.16%	75
2022 Q2	$226K	Sell	4,315 -357	-8%	-$18.2K	0.18%	69
2022 Q1	$242K	Buy	4,672 +120	+3%	+$6.23K	0.16%	75
2021 Q4	$269K	Hold	4,552	–	–	0.16%	71
2021 Q3	$196K	Hold	4,552	–	–	0.12%	75
2021 Q2	$178K	Buy	+4,552	New	+$177K	0.11%	77

Other funds holding PFE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Corsicana & Co's PFE Position: Q2 2026 in Review

Corsicana & Co increased its Pfizer (PFE) stake by 14% in Q2 2026, buying an estimated $8.24K and bringing the position to 2,615 shares worth $63K. The position accounts for 0.03% of the portfolio, ranked #144.

Corsicana & Co first reported a position in PFE in Q2 2021 and has held it in 10 quarters since. The position peaked at $269K in Q4 2021. 1,491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Corsicana & Co held 2,615 shares of Pfizer worth $63K as of Q2 2026.
Corsicana & Co bought 315 Pfizer shares in Q2 2026, an estimated $8.24K.
Pfizer made up 0.03% of Corsicana & Co's portfolio in Q2 2026, its #144 holding.
Corsicana & Co first reported a position in Pfizer in Q2 2021 and has held it in 10 quarters since.
Corsicana & Co's Pfizer position peaked at $269K in Q4 2021.
1,491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.